OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies
Rosalinda C. Roberts
Mitochondrion (2020) Vol. 56, pp. 91-101
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 60

IUPHAR review: Drug Repurposing in Schizophrenia – An Updated Review of Clinical Trials
Jihan K. Zaki, Jakub Tomasik, Sabine Bahn
Pharmacological Research (2025), pp. 107633-107633
Open Access | Times Cited: 1

Mitophagy in depression: Pathophysiology and treatment targets
Ashutosh Tripathi, Giselli Scaini, Tatiana Barichello, et al.
Mitochondrion (2021) Vol. 61, pp. 1-10
Open Access | Times Cited: 40

Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players
Juan D. Molina, Sonia Avila, Gabriel Rubio, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 39, pp. 4049-4061
Open Access | Times Cited: 28

Mitochondrial dysfunction in psychiatric disorders
Peiyan Ni, Yao Ma, Sangmi Chung
Schizophrenia Research (2022) Vol. 273, pp. 62-77
Closed Access | Times Cited: 22

Metabolic implications of axonal demyelination and its consequences for synchronized network activity: An in silico and in vitro study
Zoltán Gerevich, Richard J. Kovacs, Agustin Liotta, et al.
Journal of Cerebral Blood Flow & Metabolism (2023) Vol. 43, Iss. 9, pp. 1571-1587
Open Access | Times Cited: 12

Twelve-hour rhythms in transcript expression within the human dorsolateral prefrontal cortex are altered in schizophrenia
Madeline R. Scott, Wei Zong, Kyle D. Ketchesin, et al.
PLoS Biology (2023) Vol. 21, Iss. 1, pp. e3001688-e3001688
Open Access | Times Cited: 11

Magnetic Resonance Spectroscopy Studies of Brain Energy Metabolism in Schizophrenia: Progression from Prodrome to Chronic Psychosis
Abigail Stein, Chenyanwen Zhu, Fei Du, et al.
Current Psychiatry Reports (2023) Vol. 25, Iss. 11, pp. 659-669
Closed Access | Times Cited: 11

Abnormal microglial reactivity in gray matter of the prefrontal cortex in schizophrenia
Uranova Na, Olga V. Vikhreva, В. И. Рахманова
Asian Journal of Psychiatry (2021) Vol. 63, pp. 102752-102752
Closed Access | Times Cited: 27

Anatomical and molecular characterization of parvalbumin-cholecystokinin co-expressing inhibitory interneurons: implications for neuropsychiatric conditions
Steven F. Grieco, Kevin G. Johnston, Pan Gao, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 5293-5308
Open Access | Times Cited: 10

Microglial-Neuronal Interactions in the Caudate Nucleus in Schizophrenia with Different Courses
Olga V. Vikhreva, В. И. Рахманова, Uranova Na
Neuroscience and Behavioral Physiology (2025)
Closed Access

Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism
Alessio Canovai, Pete A. Williams
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 41-53
Open Access | Times Cited: 3

The importance of oxidative biomarkers in diagnosis, treatment, and monitoring schizophrenia patients
Elżbieta Cecerska‐Heryć, Aleksandra Polikowska, Natalia Serwin, et al.
Schizophrenia Research (2024) Vol. 270, pp. 44-56
Closed Access | Times Cited: 3

NLRP3 inflammasome mediates astroglial dysregulation of innate and adaptive immune responses in schizophrenia
Attila Szabó, Ibrahim A. Akkouh, Jordi Requena Osete, et al.
Brain Behavior and Immunity (2024)
Open Access | Times Cited: 3

Identification of 7 mitochondria-related genes as diagnostic biomarkers of MDD and their correlation with immune infiltration: New insights from bioinformatics analysis
Xiao‐Lan Liu, Yong Wu, Mingxing Li
Journal of Affective Disorders (2024) Vol. 349, pp. 86-100
Closed Access | Times Cited: 2

Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia
Carlo Idotta, Mario A. Pagano, Elena Tibaldi, et al.
The World Journal of Biological Psychiatry (2024) Vol. 25, Iss. 6, pp. 317-329
Closed Access | Times Cited: 2

Mitochondrial Damage of Lymphocytes in Patients with Acute Relapse of Schizophrenia: A Correlational Study with Efficacy and Clinical Symptoms
Aqian Hu, Faping Li, Lei Guo, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 2455-2466
Open Access | Times Cited: 10

CPEB1, a novel risk gene in recent-onset schizophrenia, contributes to mitochondrial complex I defect caused by a defective provirus ERVWE1
Yaru Xia, Xiao-Cui Wei, Wenshi Li, et al.
World Journal of Psychiatry (2021) Vol. 11, Iss. 11, pp. 1075-1094
Open Access | Times Cited: 11

Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome
Irina A. Mednova, Alexander А. Chernonosov, Elena G. Kornetova, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 850-850
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top